Street Talk

Antisense wraps up $20m placement, rights issue pending

Anthony Macdonald, Yolanda Redrup and Kanika Sood

Nov 1, 2021 – 8.51am

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Already a subscriber?

ASX-listed drug developer Antisense Therapeutics has raised $20 million in an institutional placement and will turn its attention to securing another $17 million via a rights issue.

Anthony Macdonald is a Chanticleer columnist. He is a former Street Talk co-editor and has 10 years' experience as a business journalist and worked at PwC, auditing and advising financial services companies. Connect with Anthony on Twitter. Email Anthony at a.macdonald@afr.com

Yolanda Redrup is the editor of the AFR Rich List. She previously reported on technology, healthcare and Street Talk. Connect with Yolanda on Twitter. Email Yolanda at yolanda.redrup@afr.com

Kanika Sood is a journalist based in Sydney who writes for the Street Talk column. Email Kanika at kanika.sood@afr.com.au